Molecular pharmacology of somatastatin receptor subtypes

Journal of Endocrinological Investigation

Volumn 20, Issue 6, 1997, Pages 348-367

  Patel, Y C ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Somatostatin; Somatostatin receptor; SSTR subtypes

Indexed keywords

ADENYLATE CYCLASE; CALCIUM CHANNEL; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE; POTASSIUM CHANNEL; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

AMINO ACID SUBSTITUTION; BRAIN REGION; BREAST CANCER; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; MEMBRANE BINDING; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; PHARMACOLOGY; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; CHEMISTRY; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR GENETICS; NEOPLASM; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION;

EID: 0030612281     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03350317     Document Type: Review

References (159)

1. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77, 1973.
2. Pradayrol L., Jornvall H., Mutt V., Ribet A. N-terminally extended somatostatin: the primary structure of somatostatin 28. FEBS Lett. 109: 55, 1980.
3. Patel Y.C. General aspects of the biology and function of somatostatin. In: Müller, E.E., Thorner, M.O., Weil, C. (Eds.), The role of somatostatin: basic and clinical aspects of neuroscience series. Springer-Verlag, Berlin, Vol. 4, 1992, pp. 1-16.
4. Patel Y.C., J-L Liu A.S. Galanopoulou, D.N. Papachristou. Production, action, and degradation of somatostatin. In: Jefferson L.S., Cherrington A.D. (Eds.), The Handbook of Physiology, The endocrine pancreas and regulation of metabolism, Oxford University Press, N.Y. 1997 (in press).
5. Patel Y.C., O'Neil W. Peptides derived from cleavage of prosomatostatin at carboxy and amino terminal segments: characterization of tissue and secreted forms in the rat. J. Biol. Chem. 263: 745, 1988.
6. Reichlin S. Somatostatin. N. Engl. J. Med. 309: 1495, 1556, 1983.
7. Aguila M.C., Dees W.L., Haensly W.E., McCann S.M. Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc. Natl. Acad. Sci. (USA) 88: 11485, 1991.
8. De Lecea L., Criado J.R., Prospero-Garcia O., Gautvik K.M., Schweitzer P., Danielson P.E., Dunlop C.L.M., Siggins G.R., Henriksen S.J., Sutcliffe J.G. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381: 242, 1996.
9. Fukusumi S., Kitada C., Takekawa S., Kizawa H., Sakomoto J., Miyamoto M., Hinuma S., Kitano K., Fujino M. Identification and characterization of a novel human corticostatin like peptide. Biochem. Biophys. Res. Commun. 232: 157, 1997.
10. Kanatsuka A., Makino H., Matsushima Y., Kasanuki J., Osegawa M., Kumagai A. Effect of calcium on the secretion of somatostatin and insulin from pancreatic islets. Endocrinology 108: 22547, 1981.
11. Montminy M.R., Low M.J., Tapia-Arancibia L., Reichlin S., Mandel G., Goodman R.H. Cyclic AMP regulates somatostatin mRNA accumulation in primary diencephalic cultures and in transfected fibroblast cells. J. Neurosci. 6: 1171, 1986.
12. Patel Y.C., Papachristou D.N., Zingg H.H., Farkas E.M. Regulation of islet somatostatin secretion and gene expression: selective effects of adenosine 3′, 5′ monophosphate and phorbol esters in normal islets of Langerhans and in a somatostatin producing rat islet clonal cell line 1027B2. Endocrinology 128: 1754, 1991.
13. Aguila M.C. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase. Proc. Natl. Acad. Sci. (USA) 91: 782, 1994.
14. Patel Y.C., Greenwood M.T., Panetta R., Demchyshyn L., Niznik H., Srikant C.B. Mini Review: The somatostatin receptor family. Life Sciences 57: 1249, 1995.
15. Reisine T., Bell G.I. Molecular biology of somatostatin receptors. Endocrinol. Rev. 16: 427, 1995.
16. Epelbaum J., Dournaud P., Fodor M., Viollet C. The neurobiology of somatostatin. Crit. Rev. Neurobiol. 8: 25, 1994.
17. Patel Y.C., Greenwood M.T., Panetta R., Hukovic N., Grigorakis S., Robertson L-A, Srikant C.B. Molecular biology of somatostatin receptor subtypes. Metabolism 45: 31, 1996.
18. Da Cunha A., Rausch D.M., Eiden L.E. An early increase in somatostatin mRNA expression in the frontal cortex of Rhesus monkeys infected with simian immunodeficiency virus. Proc. Natl. Acad. Sci. (USA) 92: 1371, 1995.
19. Hoyer D., Lubbert H., Bruns C. Molecular pharmacology of somatostatin receptors. Arch. Pharmacol. 350: 441, 1994.
20. Violett C., Prevost G., Maubert E., Faivre-Bauman A., Gardette R., Kordon C., Loudes C., Slama A., Epelbaum J. Molecular pharmacology of somatostatin receptors. Fundam. Clin. Pharmacol. 9: 107, 1995.
21. Lamberts S.W.J., Van Der Lely A-J., de Herder W.W. Drug therapy: octreotide. N. Engl. J. Med. 334: 246, 1996.
22. Patel Y.C., Murthy K.K., Escher E., Banville D., Spiess J., Srikant C.B. Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism 39 (Suppl. 2): 63, 1990.
23. Schonbrunn A., Tashjian A.M. Jr. Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J. Biol. Chem. 253: 6473, 1978.
24. Srikant C.B., Patel Y.C. Somatostatin receptors: identification and characterization in rat brain membranes. Proc. Natl. Acad. Sci. (USA) 78: 3930, 1981.
25. Srikant C.B., Patel Y.C. Receptor binding of somatostatin-28 is tissue specific. Nature 294: 259, 1981.
26. Reubi J-C., Cortes R., Maurer R., Probst A., Palacios J.M. Distribution of somatostatin receptors in the human brain: an autoradiographic study. Neuroscience. 18: 329, 1986.
27. Thermos, K., Reisine T. Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3. Mol. Pharmacol. 33: 370, 1988.
28. Srikant C.B., Murthy K.K., Escher E., Patel Y.C. Photoaffinity labelling of the somatostatin receptor: Identification of molecular subtypes. Endocrinology 130: 2937, 1992.
29. Brown P.J., Lee A.B., Norman M.G., Presky D.H., Schonbrunn A. Identification of somatostatin receptors by covalent labeling with a novel photoreactive somatostatin analog. J. Biol. Chem. 265: 17995, 1990.
30. He H.T., Johnson K., Thermos K., Reisine T. Purification of a putative brain somatostatin receptor. Proc. Natl. Acad. Sci. (USA) 86: 1480, 1989.
31. Eppler C.M., Zysk J.R., Corbett M., Shieh H-M. Purification of a pituitary receptor for somatostatin. The utility of biotinylated somatostatin analogs. J. Biol. Chem. 267: 15603, 1992.
32. Maletti M., Andersson M., Marie J-C., Rosselin G., Mutt V. Solubilization and partial purification of somatostatin-28 preferring receptors from hamster pancreatic beta cells. J. Biol. Chem. 267: 15620, 1992.
33. Sullivan S.J., Schonbrunn A. Distribution of somatostatin receptors in RINm5F insulinoma cells. Endocrinology 122: 1137, 1988.
34. Liebow C., Reilly C., Serrano M., Schally A.V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. (USA) 86: 2003, 1989.
35. Zeggari M., Esteve J-P., Rauly I., Cambillau C., Mazarguil H., Dufresne M., Pradayrol L., Chayvialle J-A., Vaaysse N., Susini C. Copurification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes. Biochem. J. 303: 441, 1994.
36. Pagliacci M.C., Tognellinin R., Grignani F., Nicoletti F. Inhibition of human breast cancer cell (MCF-7) growth in vitro by the somatostatin analog SMS201-995: effects on cell cycle parameters and apoptotic cell death. Endocrinology 129: 2555, 1991.
37. Nilsson L., Folkesson R. Coexistence of somatostatin receptor subtypes in the human neuroblastoma cell line LA-N-2. FEBS Lett. 401: 838, 1997.
38. Feindt J., Becker I., Blomer U., Hugo H.H., Mehdorn H.M., Kritsch B., Mentlein R. Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J. Neurochem. 65: 1997, 1995.
39. Sreedharan S.P., Kodama K.T., Peterson K.E., Goetzl E.J. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J. Biol. Chem. 264: 949, 1989.
40. Yamada Y., Post S.R., Wang K., Tager H.S., Bell G.I., Seine S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. (USA) 89: 251, 1992.
41. Kluxen F.W., Bruns C.H., Lubbert H. Expression cloning of a rat brain somatostatin receptor cDNA. Proc. Natl. Acad. Sci. (USA) 89: 4618, 1992.
42. Li X-J., Forte M., North R.A., Ross C.A., Snyder S.H. Cloning and expression of a rat somatostatin receptor enriched in brain. J. Biol. Chem. 267: 21307, 1992.
43. Yasuda K., Rens-Domiano S., Breder C.D., Law S.F., Saper C.B., Reisine T., Bell G.I. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylyl cyclase. J. Biol. Chem. 267: 20422, 1992.
44. Meyerhof W., Wulfsen I., Schonrock C., Fehr S., Richter D. Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin 14 receptor in rat brain. Proc. Natl. Acad. Sci. (USA) 89: 10267, 1992.
45. Yamada Y., Reisine T., Law S.F., Ihara Y., Kubota A., Kagimoto S., Seino M., Seino Y., Bell G.I., Seino S. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylate cyclase. Mol. Endocrinol. 6: 2136, 1992.
46. Bruno J.F., Xu Y., Song J., Berelowitz M. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc. Natl. Acad. Sci. (USA) 89: 11151, 1992.
47. Rohrer L., Raulf F., Bruns C., Buettner R., Hofstaedter F., Schule R. Cloning and characterization of a fourth human somatostatin receptor. Proc. Natl. Acad. Sci. (USA) 90: 4196, 1993.
48. Demchyshyn L.L., Srikant C.B., Sunahara R.K., Kent G., Seeman P., Van Tol H.H.M., Panetta R., Patel Y.C., Niznik H.B. Cloning and expression of a human somatostatin-14 selective receptor variant (SSTR4) located on chromosome 20. Mol. Pharmacol. 43: 894, 1993.
49. Corness J.D., Demchyshyn L.L., Seeman P., Van Tol H.H.M., Srikant C.B., Kent G., Patel Y.C., Niznik H.B. A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides. FEBS Lett. 321: 279, 1993.
50. O'Carroll A.M., Lolait S.J., Konig M., Mahan L.C. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol. Pharmacol. 42: 939, 1992.
51. Panetta R., Greenwood M.T., Warszynska A., Demchyshyn L.L, Day R., Niznik H.B., Srikant C.B., Patel Y.C. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. Mol. Pharmacol. 45: 417, 1994.
52. Vanetti M., Kouba M., Wang X., Vogt G., Hollt V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett. 311: 290, 1992.
53. Patel Y.C., Greenwood M.T., Kent G., Panetta R., Srikant C.B. Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. Biochem. Biophys. Res. Commun. 192: 28, 1993.
54. Evans C.J., Keith D.E. Jr., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science 258: 1952, 1992.
55. Wilson R., Ainscough R., Anderson K., Baaynes C., Berks M., Bonfield J., Burton J., Connell M., Copsey T., Cooper J. et al. Nature 368: 32, 1994.
56. Jung B.P., Nguyen T., Kolakowski L.F. Jr., Lynch K.R., Heng H.H.Q., George S.R., O'Dowd B.F. Discovery of a novel human G protein coupled receptor gene (GPR25) located on chromosome 1. Biochem. Biophys. Res. Commun. 230: 69, 1997.
57. Kolakowski F.L., Jung B.P., Nguyen T., Johnson M.P., Lynch K.R., Cheng R., Heng H.H.Q., George S.R., O'Dowd B.F. Characterization of a human gene related to genes encoding somatostatin receptors. FEBS Lett. 398: 253, 1996.
58. Veber D., Saperstein R., Nutt R., Friedinger R., Brady S., Curley P., Perlow D., Palveda W., Colton C., Zacchei A., Tocco D., Hoff D., Vandlen R., Gerich J., Hall L., Mandarino L., Cordes E., Anderson P., Hirschmann R. A superactive cyclic hexapeptide analog of somatostatin. Life Sci. 34: 1371, 1984.
59. Bauer W., Briner U., Doepfner W., Halber R., Huguenin R., Marbach P., Petcher T.J., Pless J. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31: 1133, 1982.
60. Taylor J.E., Bogden A.E., Moreau J.-P., Coy D.H. In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue. Biochem. Biophys. Res. Commun. 153: 81, 1988.
61. Raynor K., Murphy W.A., Coy D.H., Taylor J.E., Moreau J.-P., Yasuda K., Bell G.I., Reisine T. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linea peptides. Mol. Pharmacol. 43: 838, 1993
62. Patel Y.C., Srikant C.B. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstrl-5). Endocrinology 135: 2814, 1994.
63. Bruns C., Raulf F., Hoyer D., Schloos J., Lubbert H., Weckbecker G. Binding properties of somatostatin receptor subtypes. Metabolism 45(Suppl. 1): 17, 1996.
64. Shimon I., Taylor J.E., Dong J.Z., Bitonte R.A., Kim S., Morgan B., Coy D.H.,. Culler M.D, Melmed S. Somatostatin receptor subtype specificity in human fetal pituitary culture. J. Clin. Invest. 99: 789, 1997.
65. Liapakis G., Haeger C., Rivier J., Reisine T. Development of a selective agonist at the somatostatin receptor subtype SSTR1. J. PET 276: 1089, 1996.
66. Bass R.T., Buckwalter B.L., Patel B.P., Pausch M.H., Price L.A., Strnad J., Hadcock J.R. Identification and characterization of novel somatostatin antagonists. Mol. Pharmacol. 50: 709, 1996.
67. Baldwin J.M. Structure and function of receptors coupled to G proteins. Curr. Opin. Cell Biol. 6: 180, 1994.
68. Strader C.D., Fong T.M., Graziano M.P., Tota M.R. The family of G protein coupled receptors. FASEB J. 9: 745, 1995.
69. Schwartz T.W., Rosenkilde M.M. Is there a lock for all agonist keys in 7 TM receptors. TIPS 17: 213, 1996.
70. Gether U., Johansen T.E., Snider R.M., Lowe J.A., Edmons-Alt X., Yokota Y., Nakamishi S., Schwartzz T.W. Binding epitopes for peptide and nonpeptide ligands on the NK1 (substance P) receptor. Regul. Pept. 46: 49, 1993.
71. Hjorth S.A., Schambye H.T., Greenlee W.J., Schwartz T.W. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J. Biol. Chem. 269: 30953, 1994.
72. Flanagan C.A., Becker I.I., Davidson J.S., Wakefield I.K., Zhou W., Sealfon S.C., Miller R.P. Glutamate 301 of the mouse gonadotrophin releasing hormone receptor confers specificity for arginine 8 of mammalian gonadotrophin releasing hormone. J. Biol. Chem. 269: 22636, 1994.
73. Kaupman K., Bruns C., Raulf F., Weber H.P., Mattes H., Lubbert H. Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS201-995 for the SSTR2 somatostatin receptor. EMBO J. 14: 727, 1995.
74. Nehring R.B., Meyerhof W., Richter D. Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin 14 binding. DNA and Cell Biol. 14: 939, 1995.
75. Strnad J., Hadcock J.R. Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2. Biochem. Biophys. Res. Commun. 216: 913, 1995.
76. Fitz-Patrick V.D., Vandlen R.L. 6 agonist selectivity determinants in somatostatin receptor subtypes I and II. J. Biol. Chem. 269: 24621, 1994.
77. Greenwood M.T., Hukovic N., Kumar U., Panetta R., Hjorth S.A., Srikant C.B., Patel Y.C. Ligand binding pocket of the human somatostatin receptor 5 (hsstr5): mutational analysis of the extracellular domains. Mol. Pharmacol. 1997 (in press).
78. Luthin D.R., Eppler C.M., Linden J. Identification and quantification of Gi-type GTPbinding proteins that copurify with a pituitary somatostatin receptor. J. Biol. Chem. 268: 5990, 1993.
79. Law S.F., Yasuda K., Bell G.I., Reisine T. Gi alpha 3 and G (o) alpha selectively associate with cloned somatostatin in receptor subtypes SSTR2. J. Biol. Chem. 268: 10721, 1993.
80. Tallent M., and Reisine T. Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells. Mol. Pharmacol. 41: 452, 1992.
81. Liu Y.F., Jacobs K.H., Rosewick M.M., Albert P.R. G protein specificity in receptor effector coupling: analysis of the roles of Go and Gi in GH4CI pituitary cells. J. Biol. Chem. 269: 13880, 1994.
82. Senogles S.E. The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins. J. Biol. Chem. 269: 23120, 1994.
83. Wang H.L., Bogen C., Reisine T., Dichter M. Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons. Proc. Natl. Acad. Sci. (USA) 86: 9616, 1989.
84. Sims S.M., Lussier B.T., Kraicer J. Somatostatin activates an inwardly rectifying K+ conductance in freshly dispersed rat somatotrophs. J. Physiol. 441: 615, 1991.
85. + channels in insulinoma cells: activation by somatostatin and protein kinase C and the role of cAMP. Proc. Natl. Acad. Sci. (USA) 86: 2971, 1989.
86. + channels through protein dephosphorylation. Nature 351: 570, 1991.
87. + channels by isolated GK protein in clonal rat anterior pituitary cell membranes. Mol. Endocrinol. 1: 283, 1987.
88. Koch B.D., Schonbrunn A. Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. J. Biol. Chem. 263: 226, 1988.
89. Ikeda S.R., Schofield G.G. Somatostatin blocks a calcium current in rat sympathetic ganglion neurons. J. Physiol. 409: 221, 1989.
90. Kleuss C., Heschefeler J., Ewel C., Rosenthal W., Schultz G., Wittig B. Assignment of G protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 353: 43, 1991.
91. 2+ current modulated by cGMP-dependent protein kinase. Nature 369: 336, 1994.
92. Renstrom E., Ding W-G., Bokvist K., Rorsman P. Neurotransmitter-induced inhibition of exocytosis in insulin-secreting β cells by activation of calcineurin. Neuron 17: 513, 1996.
93. Barber, D.L., M.E. McGuire, M.B. Ganz. Beta-adrenergic and somatostatin receptors regulate Na-H exchange independent of cAMP. J. Biol. Chem. 264: 21038, 1989.
94. Schweitzer R., Madamba S., Siggins G.R. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature 346: 464, 1990.
95. Schonbrunn A. Somatostatin action in pituitary cells involves two independent transduction mechanisms. Metabolism 39 (Suppl. 2): 96, 1990.
96. Brown P., Schonbrunn A. Affinity purification of a somatostatin receptor-G-protein complex demonstrates specificity in receptor-G-protein coupling J. Biol. Chem. 268: 6668, 1993.
97. Patel Y.C., Greenwood M.T., Warszynska A., Panetta R., Srikant C.B. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem. Biophys. Res. Commun. 198: 605, 1994.
98. Florio T., Rim C., Hershberger R.E., Loda M., Stork P.J. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol. Endocrinol. 8: 1289, 1994.
99. Buscail L., Esteve J.-P., Saint-Laurent N., Bertrand V., Reisine T., O'Carroll A.-M., Bell G.I., Schally A.V., Vaysse N., Susini C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc. Natl. Acad. Sci. (USA) 92: 1580, 1995.
100. Reardon D.B., Wood S.L., Brautigan D.L., Bell G.I., Dent P., Sturgill T.W. Activation of a protein tyrosine phosphate and inactivation of Raf-1 by somatostatin. Biochem. J. 314: 401, 1996.
101. Florio T., Scarziello A., Fattore M., Dalto V., Salzano S., Rossi G., Berlingieri M.T., Fusco A., Schettini G. Somatostatin inhibits PC C13 thyroid cell proliferation through the modulation of phosphotyrosine phosphatase activity-impairment of the somatostatinergic effects by stable expression of EIA viral oncogene. J. Biol. Chem. 271: 6129, 1996.
102. Sharma K., Patel Y.C., Srikant C.B. Subtype selective human somatostatin receptor (hSSTR) mediated cytostatin and cytotoxic actions involve different signalling mechanisms. Program Annual Meeting US Endocrine Society, Minneapolis, June 1997 (abstract).
103. Hou C., Gilbert R.L., Barber D.L. Subtype-specific signalling mechanisms of somatostatin receptors SSTR1 and SSTR2. J. Biol. Chem. 269: 10357, 1994.
104. Fujii Y., Gonoi T., Yamada Y., Chihara K., Inagaki N., Seino S. Somatostatin receptor subtype SSTR2 mediates the inhibition of high voltage activated calcium channels by somatostatin and its analogue SMS201-995. FEBS Lett. 355: 117, 1994.
105. Viana F., Hille B. Modulation of high voltage-activated calcium channels by somatostatin in acutely isolated rat amygdaloid neurons. J. Neurosci. 16: 6000, 1996.
106. Bito H., Mori M., Sakanaka C., Takano T., Honda Z., Gotoh Y., Nishida E., Shimizu T. Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release and activation of the mitogen-activated protein kinase cascade. J. Biol. Chem. 269: 12722, 1994.
107. 2+ mobilization by cloned human somatostatin receptor subtypes 1-5 in transfected COS-7 cells. FEBS Lett. 348: 192, 1994.
108. Luini A., de Matteis M.A. Evidence that receptor-linked G protein inhibits exocytosis by a post-second messenger mechanism in AtT-20 cells. J. Neurochem. 54: 30, 1990.
109. Wollheim C.B., Winiger B.P., Ullrich S., Wuarin F. Schlegel W. Somatostatin inhibition of hormone release: effects on cytosolic Cal' and interference with distal secretory events. Metabolism (Suppl. 11) 39: 101, 1990.
110. Pan M.G., Florio T., Stork P.J.S. G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 256: 1215, 1992.
111. Srikant C.B., Shen S.H. Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTPIC to membranes in MCF-7 human breast cancer adenocarcinoma cells. Endocrinology 137: 3461, 1996.
112. Srikant C.B. Cell cycle dependent induction of apoptosis by somatostatin analog SMS201995 in AtT-20 mouse pituitary tumor cells. Biochem. Biophys. Res. Commun. 209: 400, 1995.
113. Sharma K., Patel Y.C., Srikant C.B. Subtype selective induction of p53-dependent apoptosis but not bell cycle arrest by human somatostatin receptor 3. Mol. Endocrinol. 10: 1688, 1996.
114. Bruno J.F., Xu Y., Song J., Berelowitz M. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133: 2561, 1993.
115. Breder C.D., Yamada Y.Y., Yasuda K., Seino S., Saper C.B., Bell G.I. Differential expression of somatostatin receptor subtypes in brain. J. Neurosci. 12: 3920, 1992.
116. Kong H., DePaoli A.M., Breder C.D., Yasuda K., Bell G.I., Reisine T. Differential expression of messenger RNAs for somatostatin receptor subtypes SSTR1, SSTR2, and SSTR3 in adult rat brain: analysis by RNA blotting and in situ hybridization histochemistry. Neuroscience 59: 175, 1994.
117. Thoss V.S., Perez J., Due D., Hoyer D. Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology 34: 1673, 1995.
118. Thoss V.S., Perez J., Probat A., Hoyer D. Expression of five somatostatin receptor mRNAs in the human brain and pituitary. Arch. Pharmacol. 354: 411-419, 1996.
119. Dournaud P., Gu Y.Z., Schonbrunn A., Mazella J., Tannenbaum G.S., Beaudet A. Localization of the somatostatin receptor SST2A in rat brain using a specific antipeptide antibody. J. Neurosci. 16: 4468, 1996.
120. Patel Y.C., Panetta R., Escher E., Greenwood M., Srikant C.B. Expression of multiple somatostatin receptor genes in AtT-20 cells: evidence for a novel somatostatin-28 selective receptor subtype. J. Biol. Chem. 269: 1506, 1994.
121. Day R., Dong W., Panetta R., Kraicer J., Greenwood M.T., Patel Y.C. Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis. Endocrinology 136: 5232, 1995.
122. O'Carroll A., Krempels K. Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary. Endocrinology 136: 5224, 1995.
123. Panetta R., Patel Y.C. Expression of mRNA for all 5 human somatostatin receptor (hSSTR1-5) in pituitary tumors. Life Sci. 56: 333, 1994.
124. Grigorakis S.I., Panetta R., Patel Y.C. Expression of mRNA for somatostatin receptor (sstr) subtypes 1-5 in islets and differential downregulation of sstr2 mRNA by SST agonists. Program Annual Meeting American Diabetes Association, June 10-13, 1995, Atlanta, Georgia, Abstr. no. 485, p. 132A.
125. Amherdt M., Patel Y.C., Orci L. Selective binding of somatostatin-14 and somatostatin -28 to islet cells revealed by quantitative electron microscopic autoradiography. J. Clin. Invest. 80: 1455, 1987.
126. Le Romancer M., Cherifi Y., Levasseur S., Laigneau J.P., Peranzi G., Jois P., Lewin M.J., Reyl-Desmars F. Messenger RNA expression of somatostatin receptor subtypes in human and rat gastric mucosae. Life Sci. 58: 1091, 1996.
127. Lamberts S.W.J., Krenning E.P., and Reubi J.-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 12: 450, 1991.
128. Greenman Y., Melmed S. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J. Clin. Endocrinol. Metab. 78: 398, 1994.
129. Greenman Y., Melmed S. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J. Clin. Endocrinol. Metab. 79: 724, 1994.
130. Miller G., Alexander M.J.M., Bikkel H.A. Somatostatin receptor subtype gene expression in pituitary adenomas. J. Clin. Endocrinol. Metab. 80: 1386, 1995.
131. Vikic-Topic S., Reisch K.P., Kvols L.K., Vuk-Pavlovic S. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J. Clin. Endocrinol. Metab. 80: 2974, 1995.
132. Kubota A., Yamada Y., Kagimoto S., Shimatsu A., Imamura M., Tsuda K., Imura H., Seino S., Seino Y. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS201-995 in treatment of human endocrine tumors. J. Clin. Invest. 93: 1321, 1994.
133. Epelbaum J., Bertherat J., Prevost G., Kordon C., Meyerhof W., Wulfsen L, Richter D., Plouin P-F. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal and malignant phaeochromocytomas. J. Clin. Endocrinol. Metab. 80: 1837, 1995.
134. Dutour A., Panetta R., Kumar U., Ouafik L., Furin F., Patel Y.C. Expression of somatostatin receptor subtypes (1-5) in human brain tumors. J. Clin. Endocrinol. Metab. 1997 (submitted).
135. Krejs G.J., Orel L., Conlon J.M., Ravazzola M., Davis G.R., Raskin P., Collins S.M., McCarthy D.M., Baetens D., Rubinstein A., Aldor T.A.M., Linger R.H. Somatostatinoma syndrome. N. Engl. J. Med. 301: 285, 1979.
136. Dohlman H.G., Thorner J., Caron M.G., Lelkowitz R.J. Model systems for the study of seven transmembrane segment receptors. J. Biol. Chem. 268: 337, 1991.
137. Reisine T.D., Axelrod J. Prolonged somatostatin treatment desensitizes somatostatin's inhibition of receptor-mediated release of adrenocorticotropin hormone and sensitizes adenylate cyclase. Endocrinology 113: 811, 1983.
138. Morel G., Leroux P., Pelletier G. Ultrastructural autoradiographic localization of somatostatin-28 in the rat pituitary gland. Endocrinology 116: 1615, 1985.
139. Amherdt M., Patel Y.C., Orci L. Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells. J. Clin. Invest. 84: 412, 1989.
140. 125I-Tyr3] octreotide by mouse and human pituitary tumor cells: increase by unlabelled octreotide. Endocrinology 136: 3698, 1995.
141. Presky D.H., Schonbrunn A. Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin. J. Biol. Chem. 263: 714, 1988
142. Hukovic N., Panetta R., Kumar U., Patel Y.C. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology 137: 4046, 1996.
143. Nouel D., Gaudriault G., Houle M., Reisine T., Vincent J-P., Mazella J., Beaudet A. Differential internalization of somatostatin in COS-7 cells transfected with SST1 and SST2 receptor subtypes: a confocal microscopic study using novel fluorescent somatostatin derivatives. Endocrinology 138: 296, 1997.
144. Roth A., Kreienkamp H.J., Nehring R.B., Roosterman D., Meyerhof W., Richter D. Endocytosis of the rat somatostatin receptors - subtype discrimination, ligand specificity and delineation of carboxyterminal positive and negative sequence motifs. DNA and Cell Biology 16: 111, 1997.
145. Vidal C., Rauly I., Zeggari M., Delesque N., Esteve J.-P., Saint-Laurent N., Vaysse N., Susini C. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells. Mol. Pharmacol. 46: 97, 1994.
146. 3 cells. Biochem. Biophys. Res. Commun. 202: 1738, 1994.
147. 1 cells. Endocrinology 136: 5070, 1995.
148. Kimura N., Hayafiji C., Konagaye H., Takahashi K. 17β estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells. Endocrinology 119: 1028, 1986.
149. Xu Y.X., Song J., Berelowitz M., Bruno J.F. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells. Endocrinology 5634, 1996.
150. Visser-Wisselaar H.A., Van Uffelen C.J.C., Van Koetsveld P.M., Lichtenauer Kaligis E.G.R., Waaijers A.M., Uitterlinden P., Movy D.M., Lamberts S.W.J., Hofland L.J. 17β estradiol dependent regulation of somatostatin receptor subtype expression in the 7315 b prolactin secreting rat pituitary tumor in vitro and in vivo. Endocrinology 138: 1180, 1997.
151. James R.A., Sarapura V.D., Bruns C., Raulf F., Dowding J.M., Gordon D.F., Wood W.M., Ridgway E.G. Thyroid hormone induced expression of specific somatostatin receptor subtypes correlates with involution of the TtT-97 murine thyrotrope tumor. Endocrinology 138: 719, 1997.
152. Bruno J.F., Xu Y., Song J., Berelowitz M. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat. Endocrinology 135: 1787, 1994.
153. Hauser F., Meyerhof W., Wulfsen I., Schonrock C., Richter D. Sequence analysis of the promoter region of the rat somatostatin receptor subtype 1 gene. FEBS Lett. 345: 225, 1994.
154. Greenwood M.T., Robertson L.-A., Patel Y.C. Cloning of the gene encoding the human somatostatin receptor 2: sequence analysis of the 5′ flanking promoter region. Gene 159: 291, 1995.
155. Pscherer A., Dorflinger U., Kirfel J., Gawlas K., Ruschoff J., Buettner R., Schule R. The helix-loop-helix transcription factor SEF2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. EMBO J. 15: 6680, 1996.
156. Xu Y., Bruno J.F., Berelowitz M. Characterization of the proximal region of the rat somatostatin receptor gene, SSTR4. Biochem. Biophys. Res. Commun. 206: 935, 1995.
157. Greenwood M.T., Panetta R., Robertson L.A. Liu J-L, Patel Y.C. Sequence analysis of the 5′-flanking promoter region of the human somatostatin receptor 5. Biochem. Biophys. Res. Commun. 205: 1883, 1994.
158. Sanford R., Sgotto B., Burn T., Brenner S. The tuberin (TSC2) autosomal dominant polycystic kidney disease (PKD1) and somatostatin type V receptor (SSTR5) genes form a synteny group in the fugu genome. Genomics 38: 84, 1996.
159. Brassier J., Henske E.P. Loss of the polycystic kidney (PKD 1) region of chromosome 1 6pl 3 in renal cyst cells support a loss of function model for cyst pathogenesis. J. Clin. Invest. 99. 194, 1997.